Production Capacity and Client Advantages - The company has three production bases in Changsha, Shanghai, and Dongguan, with an annual production capacity of approximately 550,000 tons for surfactants and 250,000 tons for cleaning products [2][3] - The company has established long-term strategic partnerships with major clients such as Procter & Gamble, Blue Moon, and Colgate, benefiting from stable product quality and location advantages [2][3] Product Applications and Industry Position - The surfactant products include AES, LAS, K12, ammonium salts, AOS, and amino acid types, primarily used in daily detergents, cosmetics, personal care products, and agricultural aids, ranking among the top two in the industry for production and sales in 2024 [3][4] - The company leverages its extensive experience in the cleaning products sector to enhance product quality and customer loyalty through integrated supply chain advantages [3][4] Market Trends and R&D Investments - The cleaning industry is experiencing growth due to increased consumer awareness of hygiene and government support for green products, with a notable rise in demand for home cleaning products [4][5] - R&D expenses increased by 11.67%, focusing on optimizing liquid amino acid surfactant processes and developing low-freezing-point fatty alcohol ether sulfates [4][5] Environmental Initiatives - The company is committed to green development, having passed ISO certifications for greenhouse gas emissions and product carbon footprints, and is recognized as a "National Green Factory" [5][6] Financial Performance and Future Plans - In 2024, the company achieved a revenue of 3.649 billion yuan, reflecting a growth of 12.31% due to increased production capacity and rising raw material prices [6][7] - Future plans include expanding surfactant production, enhancing product technology, and establishing the Guangdong base as a key low-carbon supply chain factory [6][7] Competitive Strategy - The company aims to maintain and enhance market share through innovation, cost leadership, and brand development, focusing on high-quality growth and expanding into high-end daily chemicals and biopharmaceuticals [7]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001218 证券简称：丽臣实业 公告编号：2025-016 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ （二） 非经常性损益项目和金额 √适用 □不适用 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第一季度报告是否经审计 单位：元 ■ 其他符合非经常性损益定义的损益项目的具体情况 □适用 √不适用 公司不存在其他符合非经常性损益定义的损益项目的具体情况。 将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》中列举的非经常性损益项目界 定为经常性损益项目的情况说明 □适用 √不适用 公司不存在将《公开发行证券的公司信息披露解释性公告 ...

湖南丽臣实业股份有限公司监事会 关于 2025 年第一季度报告的审核意见 根据《中华人民共和国公司法》《中华人民共和国证券法》以及中国证监会、 深圳证券交易所的有关规定，湖南丽臣实业股份有限公司（以下简称"公司"） 第五届监事会第二十一次会议于 2025 年 4 月 29 日在公司会议室以现场方式召开， 与会监事对公司 2025 年第一季度报告进行了认真的审核，发表审核意见如下： 经审核，公司监事会成员一致认为，公司董事会编制和审议公司《2025 年 第一季度报告》的程序符合法律、行政法规和中国证监会及深圳证券交易所的有 关规定，报告内容真实、准确、完整地反映了公司的实际情况，不存在任何虚假 记载、误导性陈述或者重大遗漏。 湖南丽臣实业股份有限公司监事会 2025 年 4 月 29 日 ...

Financial Performance - The company's revenue for Q1 2025 reached ¥1,054,889,511.23, representing a 25.83% increase compared to ¥838,351,240.61 in the same period last year[5] - Net profit attributable to shareholders decreased by 14.90% to ¥27,656,536.17 from ¥32,498,857.74 year-on-year[5] - Basic and diluted earnings per share fell by 19.23% to ¥0.21 from ¥0.26 in the same quarter last year[5] - Total operating revenue for the current period reached ¥1,054,889,511.23, an increase of 25.8% compared to ¥838,351,240.61 in the previous period[20] - Net profit for the current period was ¥27,656,536.17, a decrease of 14.2% from ¥32,498,857.74 in the previous period[21] Cash Flow - The net cash flow from operating activities turned negative at -¥9,873,532.55, a decline of 112.61% from ¥78,292,781.16 in the previous year[5] - Cash flow from operating activities showed a net outflow of ¥9,873,532.55, compared to a net inflow of ¥78,292,781.16 in the previous period[24] - The company incurred a net cash outflow from investment activities of ¥161,688,600.04, compared to a net outflow of ¥116,303,534.83 in the previous period[24] - The company reported a total cash inflow from investment activities of ¥141,367,445.36, compared to ¥78,019.98 in the last period[24] Assets and Liabilities - The total assets at the end of Q1 2025 were ¥2,898,212,721.52, a 1.20% increase from ¥2,863,914,472.60 at the end of 2024[5] - Current assets total 1,639,338,299.36 RMB, down from 1,694,170,761.50 RMB at the beginning of the period[18] - Cash and cash equivalents decreased to 452,322,045.73 RMB from 662,540,491.85 RMB[18] - Total liabilities stand at 659,160,909.37 RMB, slightly up from 658,427,256.73 RMB[19] - The company's equity attributable to shareholders is 2,239,051,812.15 RMB, an increase from 2,205,487,215.87 RMB[19] Shareholder Information - Total number of common shareholders at the end of the reporting period is 14,349[15] - The largest shareholder, Jia Qizheng, holds 16.78% of shares, totaling 21,840,000 shares[15] - The number of shares held by the top ten shareholders includes significant stakes from Jia Qizheng, Hou Bingyang, and Sun Jianxiong, each holding over 4%[15][16] - The company has no preferred shareholders or significant changes in the top ten shareholders due to margin trading activities[17] Research and Development - Research and development expenses increased by 33.55% to ¥40,180,228.92 compared to ¥30,086,789.00 in Q1 2024, indicating a focus on innovation[11] - Research and development expenses increased to ¥40,180,228.92, up 33.5% from ¥30,086,789.00 in the last period[20] Investment Income - The company reported a significant increase in trading financial assets by 118.98% to ¥175,735,600.99, attributed to the investment of idle funds[10] - The company experienced a 424.68% increase in investment income to ¥366,754.40, driven by returns from wealth management products[12] - The company received tax refunds amounting to ¥20,503,899.70, compared to ¥14,079,247.57 in the last period[24]

Core Viewpoint - The company has proposed a profit distribution plan for the year 2024, which includes a cash dividend of RMB 5.10 per 10 shares, amounting to a total cash dividend of RMB 66,390,912.60, subject to approval at the upcoming shareholders' meeting [2][3][4]. Group 1: Profit Distribution Plan - The profit distribution plan is based on the 2024 fiscal year, with a net profit attributable to shareholders of RMB 109,117,424.41, after accounting for statutory surplus reserves and previous distributions [5]. - The total distributable profit for shareholders is determined to be RMB 110,592,543.29, based on the lower of the consolidated and parent company financial statements [5][6]. - The company plans to distribute cash dividends without issuing new shares or using reserves for capital increase, adhering to the guidelines from the China Securities Regulatory Commission [6][10]. Group 2: Approval Process - The profit distribution proposal was approved by the company's board and supervisory committee and will be submitted for approval at the 2024 annual shareholders' meeting [4][11]. - The proposal is compliant with relevant laws and regulations, ensuring it does not harm the interests of shareholders, particularly minority shareholders [11][12]. Group 3: Cash Dividend Justification - The cash dividend plan is justified by the company's operating performance and cash flow, aligning with its established profit distribution policy [10][13]. - The cumulative cash dividends over the last three years exceed 30% of the average annual net profit, indicating a stable return to shareholders [9].

证券代码：001218 证券简称：丽臣实业 公告编号：2025-015 湖南丽臣实业股份有限公司 关于 2024 年度利润分配预案专项说明的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、每10股派发现金红利人民币5.10元（含税），不送红股，不以公积金转增股本，共计 派发现金股利66,390,912.60元（含税）。 2、在实施权益分派的股权登记日前公司总股本发生变动的，则以实施分配方案时股权 登记日的享有利润分配权的股份总额为基数，按照每股分配比例不变的原则，相应调整分配 总额。 3、2024年度现金分红方案不触及《深圳证券交易所股票上市规则》第9.8.1条规定的可 能被实施其他风险警示情形。 4、本次利润分配方案尚待公司股东会审议通过后方可实施。 （一）2024 年度利润分配方案的基本内容 1、分配基准：2024 年度。 2、经致同会计师事务所（特殊普通合伙）出具的 2024 年度审计报告，公司 2024 年度实现归属于母公司股东的净利润为 109,117,424.41 元，扣除计提的法定 盈余公积金 2,570,386.01 元， ...

Core Viewpoint - The company, Lichen Industrial Co., Ltd., focuses on the research, production, and sales of surfactants and cleaning products, with a strong market position in the surfactant industry, particularly in anionic surfactants, where it ranks among the top two in China for production and sales volume in 2024 [3][6]. Company Overview - Lichen Industrial specializes in surfactants and cleaning products, with surfactants being the primary source of revenue and profit, utilized in various sectors including daily cleaning agents, cosmetics, personal care products, agricultural additives, and construction materials [2][3]. - The company operates three production bases located in Changsha, Shanghai, and Dongguan, with an annual production capacity of approximately 550,000 tons for surfactants and 250,000 tons for cleaning products [2]. Business Segments - **Surfactant Business**: The company produces a range of surfactants including AES, LAS, K12, ammonium salts, AOS, and amino acid types, primarily used in daily cleaning agents and cosmetics, maintaining a leading position in the industry [3]. - **Cleaning Products**: The product line includes laundry powder, liquid detergents, hotel cleaning products, and industrial cleaning solutions, utilizing both proprietary brands and OEM models [4]. Operational Model - **Production Model**: The company employs a sales-driven production approach, adjusting monthly production plans based on sales forecasts and inventory levels, with most products produced in-house [4][5]. - **Sales Model**: The sales strategy includes direct sales for surfactants (90% of sales) and a mix of direct and distributor sales for cleaning products, focusing on regional markets and providing after-sales service [4]. Market Position - The company is a significant player in the anionic surfactant market in China, with a high industry concentration and a top-two ranking in production and sales volume for its main surfactant products in 2024 [6]. Financial Data - The company has not required restatement of previous financial data, indicating stable financial reporting practices [7][8].

湖南丽臣实业股份有限公司 2024 年度监事会工作报告 湖南丽臣实业股份有限公司 2024 年度监事会工作报告 2024 年，公司监事会全体成员按照《中华人民共和国公司法》 （以下简称"《公司法》"）、《中华人民共和国证券法》（以下简 称"《证券法》"）、《湖南丽臣实业股份有限公司章程》（以下简 称"《公司章程》"）和《湖南丽臣实业股份有限公司监事会议事规 则》（以下简称"《监事会议事规则》"）等规定和要求，认真履行 监事职责，依法独立行使职权，有效保障股东权益、公司利益和员工 的合法权益不受侵犯。监事会对公司生产经营活动、重大事项、财务 状况以及公司董事、高级管理人员履行职责情况等进行监督，促进了 公司规范运作。现将监事会在 2024 年度的主要工作报告如下： 一、2024 年监事会工作情况 报告期内，监事会认真履行工作职责，审慎行使《公司章程》和 股东大会赋予的职责，共召开了 6 次会议，全体监事均亲自出席会议， 不存在缺席会议的情况。全体监事对提交至监事会审议的议案未提出 异议。监事会会议的召开及表决程序符合《公司法》《公司章程》的 要求。 | 序 | 会议召 | | 会议届次 | 会议决议事项 | | ...

证券代码：001218 证券简称：丽臣实业 公告编号：2025-010 湖南丽臣实业股份有限公司 2024 年度募集资金存放与使用情况专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 根据《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要 求》（2022 年修订）和《深圳证券交易所上市公司自律监管指引第 1 号——主板 上市公司规范运作》有关规定，湖南丽臣实业股份有限公司（以下简称"公司"） 现将 2024 年度募集资金存放与使用情况说明如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 经中国证券监督管理委员会《关于核准湖南丽臣实业股份有限公司首次公开 发行股票的批复》（证监许可[2021]2977 号）核准，公司首次公开发行人民币普 通股（A 股）股票 2,250 万股，每股面值 1.00 元，每股发行价 45.51 元，共募集 资金人民币 102,397.50 万元，扣除保荐承销费用等发行费用（不含增值税）影响 后的募集资金净额为人民币 93,669.99 万元，其中：新增注册资本人民币 2,250 万 元，资本公 ...

湖南丽臣实业股份有限公司（以下简称"公司"）2024年度财务报表已经 致同会计师事务所（特殊普通合伙）审计并出具了标准无保留意见的审计报告。 会计师的审计意见是：公司2024年度财务报表在所有重大方面按照企业会计准 则的规定编制，公允反映了公司2024年12月31日的合并及公司财务状况以及 2024年度的合并及公司经营成果和现金流量。现将公司2024年度财务报表反映 的主要财务数据报告如下（除特别说明外金额单位均为人民币万元）： | 项 目 | 2024年度 | 2023年度 | 本年比上年增减 | | --- | --- | --- | --- | | 营业收入 | 364,912.70 | 324,915.33 | 12.31% | | 营业利润 | 12,281.14 | 14,297.29 | -14.10% | | 利润总额 | 11,962.80 | 14,202.27 | -15.77% | | 归属于上市公司股东的净利润 | 10,911.74 | 13,572.05 | -19.60% | | 扣除非经常性损益后归属于上市 | 10,249.86 | 12,618.56 | -18.77% ...